BARCLAYS PLC

Position in INCY — Incyte Corp

CIK 312069 LONDON, X0

Back to INCY Full portfolio

Position in INCY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$34,550,980

-$4,148,982 QoQ

Shares Held

367,095

-6.3% QoQ

Ownership

0.184%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in INCY Over Time

Shares Held

Position Value (USD)

Derivatives in INCY

reported options exposure · as of Sep 30, 2025

CallValue

$2,289,870

CallShares

27,000

PutValue

$2,289,870

PutShares

27,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. INCY ranks #9 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

All Filings in INCY

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$34,550,980	367,095	-6.3%	Shares	Defined	2026-05-15
2025-12-31	$38,699,962	391,819	+1351.2%	Shares	Sole	2026-02-13
2025-09-30	$2,289,870	27,000	-94.5%	Call	Sole	2026-03-31
2025-09-30	$41,398,388	488,131	+1707.9%	Shares	Sole	2026-03-31
2025-09-30	$2,289,870	27,000	-97.4%	Put	Sole	2026-03-31
2025-06-30	$70,159,955	1,030,249	+15.2%	Shares	Sole	2026-02-27
2025-03-31	$54,169,905	894,631	+20.6%	Shares	Sole	2026-03-17
2024-12-31	$51,230,945	741,725	+2647.1%	Shares	Sole	2026-03-19
2024-12-31	$1,864,890	27,000	0.0%	Call	Sole	2026-03-19
2024-12-31	$1,864,890	27,000	-97.4%	Put	Sole	2026-03-19
2024-09-30	$68,210,704	1,031,932	+1619.9%	Shares	Sole	2026-03-31
2024-06-30	$3,637,200	60,000	-93.3%	Call	Sole	2026-03-23
2024-06-30	$54,217,921	894,390	+81.3%	Shares	Sole	2026-03-23
2024-03-31	$28,105,863	493,345	+1544.5%	Shares	Sole	2026-03-24
2024-03-31	$1,709,100	30,000	0.0%	Call	Sole	2026-03-24
2024-03-31	$1,709,100	30,000	-93.9%	Put	Sole	2026-03-24
2023-12-31	$30,631,660	487,843	+18.7%	Shares	Sole	2026-03-24
2023-09-30	$23,751,557	411,140	+0.1%	Shares	Sole	2026-03-26
2023-06-30	$25,570,245	410,767	-11.7%	Shares	Sole	2026-03-27
2023-03-31	$33,625,566	465,277	+10.4%	Shares	Sole	2026-03-30
2022-12-31	$33,840,101	421,316	-76.4%	Shares	Sole	2026-03-30
2022-09-30	$119,105,337	1,787,295	+197.1%	Shares	Sole	2022-11-03
2022-06-30	$45,708,717	601,668	+154.4%	Shares	Sole	2022-08-12
2022-03-31	$18,783,385	236,507	+885.4%	Shares	Sole	2022-05-16
2022-03-31	$1,906,080	24,000	0.0%	Call	Sole	2022-05-16
2021-12-31	$1,761,600	24,000	-93.3%	Call	Sole	2022-02-23
2021-12-31	$26,366,748	359,220	-8.4%	Shares	Sole	2022-02-23
2021-09-30	$26,986,313	392,357	+30.8%	Shares	Sole	2021-11-09
2021-06-30	$25,232,268	299,920	+11.5%	Shares	Sole	2021-08-13
2021-03-31	$21,866,505	269,060	+20.8%	Shares	Sole	2021-05-13
2020-12-31	$19,370,531	222,701	+2294.6%	Shares	Sole	2021-02-11
2020-12-31	$808,914	9,300	-94.9%	Put	Sole	2021-02-11
2020-09-30	$16,376,831	182,492	+1862.3%	Shares	Sole	2020-11-12
2020-09-30	$834,582	9,300	-93.8%	Put	Sole	2020-11-12
2020-06-30	$15,584,166	149,891	+1511.7%	Shares	Sole	2020-08-12
2020-06-30	$966,921	9,300	-94.1%	Put	Sole	2020-08-12
2020-03-31	$11,558,035	157,832	+197.8%	Shares	Sole	2020-05-13
2020-03-31	$3,881,190	53,000	+53.2%	Put	Sole	2020-05-13
2020-03-31	$2,533,758	34,600	—	Call	Sole	2020-05-13
No filing history on record for this holder in this stock.